The 13th Annual eyeforpharma Japan is a conference focused on a clear strategy for rwe and commercial success up to and beyond 2025.
The 13th Annual eyeforpharma Japan covers topics such as:
- Tomorrow’s winner will prioritise innovation – and inspire the workforce
- Turning RWD into a strategic asset leveraging a collaboration platform
- Shift from competition to collaboration with other pharma firms
- How digital health solutions are redefining the future trajectory of pharma companies like yours
- The importance of access to data in informing clinical practice – from safety, efficacy and affordability to epidemiology
- Develop a distinctive launch strategy by learning lessons from rare disease
- Determine the best combination of digital tools and medicines to generate the greatest cancer treatment outcomes
- Use Real World data for clinical development and safety validation post-market surveillance
The 13th Annual eyeforpharma Japan brings together Director, VP and C-suite level decision makers working in:
- Sales
- Marketing
- Digital
- Rwe
- Market access
- Medical
